Reply to ‘Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab’ – (Eye Journal AOP)

19 June 2015

This news item is available to RCOphth members only, please log in below to access.